Abstract
Background models to predict survival and treatment response have gained importance in oncology with the emergence of new prognostic factors. Most models have excellent performance in the population in which they are derived, but have limitations for application in different populations. Thus, the aim of our study is to validate the PREDICT model, developed in the United Kingdom, in a bre…